Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP318269.RAG5_SB8QXE8c8TeDQ5fn-TkdfCWNFa8ag1ngQWm9NYbU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP318269.RAG5_SB8QXE8c8TeDQ5fn-TkdfCWNFa8ag1ngQWm9NYbU130_assertion type Assertion NP318269.RAG5_SB8QXE8c8TeDQ5fn-TkdfCWNFa8ag1ngQWm9NYbU130_head.
- NP318269.RAG5_SB8QXE8c8TeDQ5fn-TkdfCWNFa8ag1ngQWm9NYbU130_assertion description "[As an inhibitor of AKT2, miR-184 could be of potential benefit in miRNA mediated therapeutics of MYCN amplified neuroblastoma and other forms of cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP318269.RAG5_SB8QXE8c8TeDQ5fn-TkdfCWNFa8ag1ngQWm9NYbU130_provenance.
- NP318269.RAG5_SB8QXE8c8TeDQ5fn-TkdfCWNFa8ag1ngQWm9NYbU130_assertion evidence source_evidence_literature NP318269.RAG5_SB8QXE8c8TeDQ5fn-TkdfCWNFa8ag1ngQWm9NYbU130_provenance.
- NP318269.RAG5_SB8QXE8c8TeDQ5fn-TkdfCWNFa8ag1ngQWm9NYbU130_assertion SIO_000772 20409325 NP318269.RAG5_SB8QXE8c8TeDQ5fn-TkdfCWNFa8ag1ngQWm9NYbU130_provenance.
- NP318269.RAG5_SB8QXE8c8TeDQ5fn-TkdfCWNFa8ag1ngQWm9NYbU130_assertion wasDerivedFrom befree-20140225 NP318269.RAG5_SB8QXE8c8TeDQ5fn-TkdfCWNFa8ag1ngQWm9NYbU130_provenance.
- NP318269.RAG5_SB8QXE8c8TeDQ5fn-TkdfCWNFa8ag1ngQWm9NYbU130_assertion wasGeneratedBy ECO_0000203 NP318269.RAG5_SB8QXE8c8TeDQ5fn-TkdfCWNFa8ag1ngQWm9NYbU130_provenance.